Industries
Cryogenics and Biobanking
Cryogenics and biobanking infrastructure supports drug discovery, cell therapy manufacturing, and biomedical research by preserving biological samples at ultra-low temperatures. As cell and gene therapy pipelines expand, companies require advanced cryopreservation protocols and DMSO-free media developed by academic cryobiology groups.
Details
- Companies
- Chart Industries BiomedicalThermo Fisher BioRepositorySTEMCELL TechnologiesCryoPortArctikoMVE ChartWorthington IndustriesBiolife SolutionsCustom Biogenic SystemsLICOR
- Market Size
- $3.1B
- Target Researchers
- Cryobiologists, biobanking managers, and biomedical engineers specializing in cryopreservation protocols, DMSO-free cryoprotectants, long-term sample stability, vapor-phase liquid nitrogen storage, and biorepository informatics
- Use Cases
- DMSO-free cryoprotectant licensingBiorepository LIMS software partnershipsCryogenic sample transport solutionsLong-term specimen stability studiesCord blood and tissue bank supply contractsCell therapy cold-chain logistics partnerships